IMMUNOGENE FÜR HIV-IMPFSTOFF
European patent · EP3891170 · In force
Register entry
- Publication number
- EP3891170
- Application number
- EP19893005
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 27, 2019
- Published
- Oct 13, 2021
- Granted
- Jul 31, 2024
- Protection ends at the latest
- Nov 26, 2039
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C07K 14/005 (2006.01)C07K 14/15 (2006.01)C07K 14/155 (2006.01)A61K 39/21 (2006.01)A61K 39/00 (2006.01)C07K 14/16 (2006.01)A61P 31/18 (2006.01)
- Priority
- US 201862775192 P 04.12.2018
- PCT application
- PCT/US2019/063619 27.11.2019
- PCT publication
- WO2020/117590 11.06.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Jun 11, 2025
Change
Published in Swissreg on 11.06.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Oct 29, 2024
Agent entered
- Representative
- BOVARD AG, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 29.10.2024
- Jul 31, 2024
Granted
Published in Swissreg on 31.07.2024
Parties
Holder
Inventor
BJORKMAN, Pamela, J.
Altadena, CA 91001, US
ESCOLANO, Amelia
New York, NY 10065, US
GRISTICK, Harry
Pasadena, CA 91125, US
NUSSENZWEIG, Michel
New York, NY 10128, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.